Reply to @Boffin99
I am not sure I understand your question. Are you asking if the sensitivity shown in those mutations is a result of FTO inhibition?
I was just quoting Dr Verrill's paper. I saw from the ASH abstract that KRAS was an identified mutation in Case Study 1 and I'm speculating that they may have found other mutations in the same study like NRAS and KIT which seem to also be associated with AML. I could be completely wrong, chatgpt is likely dangerous in the wrong hands...
Ann: Zantrene highly effective in EMD AML Mouse Model, page-115
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
